Stem definition | Drug id | CAS RN |
---|---|---|
5349 | 1234423-95-0 |
None
None
Date | Agency | Company | Orphan |
---|---|---|---|
Sept. 12, 2019 | FDA | ARDELYX INC |
None
None
Source | Code | Description |
---|---|---|
ATC | A06AX08 | ALIMENTARY TRACT AND METABOLISM DRUGS FOR CONSTIPATION DRUGS FOR CONSTIPATION Other drugs for constipation |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Irritable bowel syndrome characterized by constipation | indication | 440630006 | |
Gastrointestinal obstruction | contraindication | 126765001 |
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 9.53 | acidic |
pKa2 | 10.13 | acidic |
pKa3 | 13.34 | acidic |
pKa4 | 13.74 | acidic |
pKa5 | 7.19 | Basic |
pKa6 | 6.59 | Basic |
None
Formulation strength | Trade name | Applicant | Application number | Approval date | Type | Dose form | Route | Exclusivity date | Description |
---|---|---|---|---|---|---|---|---|---|
EQ 50MG BASE | IBSRELA | ARDELYX INC | N211801 | Sept. 12, 2019 | DISCN | TABLET | ORAL | Sept. 12, 2024 | NEW CHEMICAL ENTITY |
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Sodium/hydrogen exchanger 3 | Transporter | INHIBITOR | IC50 | 9.06 | SCIENTIFIC LITERATURE | DRUG LABEL |
ID | Source |
---|---|
1234365-97-9 | SECONDARY_CAS_RN |
C4045694 | UMLSCUI |
CHEMBL3304485 | ChEMBL_ID |
CHEMBL3301627 | ChEMBL_ID |
D11652 | KEGG_DRUG |
71587953 | PUBCHEM_CID |
C000599417 | MESH_SUPPLEMENTAL_RECORD_UI |
9652 | INN_ID |
DB11761 | DRUGBANK_ID |
WYD79216A6 | UNII |
8449 | IUPHAR_LIGAND_ID |
2199673 | RXNORM |
37400 | MMSL |
d09370 | MMSL |
018117 | NDDF |
018118 | NDDF |
789705000 | SNOMEDCT_US |
792892003 | SNOMEDCT_US |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
IBSRELA | HUMAN PRESCRIPTION DRUG LABEL | 1 | 73154-050 | TABLET | 53.20 mg | ORAL | NDA | 27 sections |